Hyperuricemia induces endothelial dysfunction

Slides:



Advertisements
Similar presentations
Volume 65, Issue 5, Pages (May 2004)
Advertisements

Volume 67, Issue 5, Pages (May 2005)
Volume 68, Issue 4, Pages (October 2005)
Volume 66, Issue 2, Pages (August 2004)
Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells  Zhenmin Ni, Stephen Hou, Cyril H. Barton,
Volume 57, Issue 1, Pages (January 2000)
Volume 57, Issue 1, Pages (January 2000)
Volume 62, Issue 2, Pages (August 2002)
Ruisheng Liu, Oscar A. Carretero, Yilin Ren, Jeffrey L. Garvin 
Volume 68, Issue 2, Pages (August 2005)
Volume 55, Issue 5, Pages (May 1999)
Human mesangial cells express inducible macrophage scavenger receptor
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 57, Issue 5, Pages (May 2000)
Robert Earl Routh, John Hardwick Johnson, Kevin John McCarthy 
Volume 66, Issue 1, Pages (July 2004)
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 68, Issue 5, Pages (November 2005)
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden  S.N. Davison, G.S.
Volume 77, Issue 1, Pages 5-6 (January 2010)
Volume 68, Issue 4, Pages (October 2005)
Volume 54, Issue 4, Pages (October 1998)
Comorbidity and confounding in end-stage renal disease
The Role of Endothelial Cell Injury in Thrombotic Microangiopathy
Volume 87, Issue 2, Pages (February 2015)
The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine  Zhiwei Xu, PhD, Taohua Lan, MD, Weikang Wu,
Volume 66, Issue 2, Pages (August 2004)
Endothelial cells as vascular salt sensors
The third World Kidney Day: Looking back and thinking forward
Volume 74, Issue 6, Pages (September 2008)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension  Zhenmin Ni, Shahrooz Bemanian, Salah D. Kivlighn,
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Alternate-day dialysis may be needed for hemodialysis patients
AGEs in foods: Do they play a role in uremia?
Volume 61, Issue 6, Pages (June 2002)
Volume 58, Issue 4, Pages (October 2000)
Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties  Gary B. Schwochau, Karl A. Nath, Mark E. Rosenberg 
Volume 54, Pages S20-S24 (December 1998)
Volume 56, Pages S178-S181 (July 1999)
Volume 68, Issue 4, Pages (October 2005)
UVA-Induced Immune Suppression Through an Oxidative Pathway
Volume 57, Issue 2, Pages (October 2000)
Volume 55, Issue 2, Pages (February 1999)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 55, Issue 6, Pages (June 1999)
Volume 64, Issue 3, Pages (September 2003)
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Video-imaging microfluorometry identifies α- and β-like cell types in Madin-Darby canine kidney monolayers  Stephanie Ebner, Marcos Marin-Grez  Kidney.
Organ transplantation goes to the movies
Volume 83, Issue 5, Pages (May 2013)
Volume 60, Issue 6, Pages (December 2001)
Volume 70, Issue 3, Pages (August 2006)
Volume 59, Issue 1, Pages (January 2001)
Volume 71, Issue 9, Pages (May 2007)
Volume 61, Issue 3, Pages (March 2002)
Volume 62, Issue 5, (November 2002)
The international realities of live donor kidney transplantation
Volume 58, Issue 2, Pages (August 2000)
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride,
Volume 55, Issue 4, Pages (April 1999)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Volume 56, Issue 5, Pages (November 1999)
Biochemical profile of idiopathic uric acid nephrolithiasis
Effect of IS on proliferation, senescence, and the production of NO and ROS from endothelial cells. Effect of IS on proliferation, senescence, and the.
Presentation transcript:

Hyperuricemia induces endothelial dysfunction Uday M. Khosla, Sergey Zharikov, Jennifer L. Finch, Takahiko Nakagawa, Carlos Roncal, Wei Mu, Karina Krotova, Edward R. Block, Sharma Prabhakar, Richard J. Johnson  Kidney International  Volume 67, Issue 5, Pages 1739-1742 (May 2005) DOI: 10.1111/j.1523-1755.2005.00273.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 The relationship of serum uric acid (UA) and serum nitrites (NOX) at 1 and 7 days. Kidney International 2005 67, 1739-1742DOI: (10.1111/j.1523-1755.2005.00273.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Correlation of serum uric acid (UA) and serum nitrites (NOX). Kidney International 2005 67, 1739-1742DOI: (10.1111/j.1523-1755.2005.00273.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Effects of uric acid (UA) on nitric oxide production by bovine aortic endothelial cells (BAEC). Cultured BAEC growing on 30 mm dishes with a glass bottom were treated with 2.5 to 7.5 mg/dL uric acid in RPMI culture media without serum for 24 hours. Visualization of nitric oxide (NOO production using a fluorescent probe 4,5-diaminofluorescein (DAF-FM) has been done as described in the Methods section. (A) Intensity of DAF fluorescence inside four control cells and four cells treated with uric acid (2.5, 5.0, or 7.5 mg/dL) was quantified every 5 minutes for 20 minutes. Intensity at the 0 point time was taken as a background and all measurements were corrected by subtracting background fluorescence. Each point represents an average DAF fluorescence in one cell +/- SD. All changes in nitric oxide production in BAEC treated with 5.0 and 7.5 mg/dL uric acid were significant compared with control BAEC with P < 0.05 (an unpaired, two-tailed Student t test). (B) DAF fluorescence images of control (A1 and A2) BAEC and BAEC treated with 7.5 mg/dL uric acid (B1 and B2). The images of fluorescence were made just after the procedure of DAF-FM de-esterification (the 0 time point; see the Methods section) (A1 and B1) and after the 20-minute period of measurements (A2 and B2). Kidney International 2005 67, 1739-1742DOI: (10.1111/j.1523-1755.2005.00273.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Effects of uric acid (UA) on nitric oxide production by bovine aortic endothelial cells (BAEC). Cultured BAEC growing on 30 mm dishes with a glass bottom were treated with 2.5 to 7.5 mg/dL uric acid in RPMI culture media without serum for 24 hours. Visualization of nitric oxide (NOO production using a fluorescent probe 4,5-diaminofluorescein (DAF-FM) has been done as described in the Methods section. (A) Intensity of DAF fluorescence inside four control cells and four cells treated with uric acid (2.5, 5.0, or 7.5 mg/dL) was quantified every 5 minutes for 20 minutes. Intensity at the 0 point time was taken as a background and all measurements were corrected by subtracting background fluorescence. Each point represents an average DAF fluorescence in one cell +/- SD. All changes in nitric oxide production in BAEC treated with 5.0 and 7.5 mg/dL uric acid were significant compared with control BAEC with P < 0.05 (an unpaired, two-tailed Student t test). (B) DAF fluorescence images of control (A1 and A2) BAEC and BAEC treated with 7.5 mg/dL uric acid (B1 and B2). The images of fluorescence were made just after the procedure of DAF-FM de-esterification (the 0 time point; see the Methods section) (A1 and B1) and after the 20-minute period of measurements (A2 and B2). Kidney International 2005 67, 1739-1742DOI: (10.1111/j.1523-1755.2005.00273.x) Copyright © 2005 International Society of Nephrology Terms and Conditions